These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33132109)

  • 1. Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives.
    Zong Y; Montironi R; Massari F; Jiang Z; Lopez-Beltran A; Wheeler TM; Scarpelli M; Santoni M; Cimadamore A; Cheng L
    Eur Urol Focus; 2021 Sep; 7(5):955-963. PubMed ID: 33132109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal carcinoma of the prostate.
    Szentirmai E; Giannico GA
    Pathologica; 2020 Mar; 112(1):17-24. PubMed ID: 32202536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent insights on the clinical, pathological, and molecular features of intraductal carcinoma of the prostate.
    Naito Y; Kato M; Nagayama J; Sano Y; Matsuo K; Inoue S; Sano T; Ishida S; Matsukawa Y; Tsuzuki T; Akamatsu S
    Int J Urol; 2024 Jan; 31(1):7-16. PubMed ID: 37728330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate.
    Kang M; Lee H; Byeon SJ; Kwon GY; Jeon SS
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal carcinoma of the prostate.
    Robinson B; Magi-Galluzzi C; Zhou M
    Arch Pathol Lab Med; 2012 Apr; 136(4):418-25. PubMed ID: 22458904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal carcinoma of the prostate: What we know and what we do not know.
    Chen X; Ding B; Zhang P; Geng S; Xu J; Han B
    Pathol Res Pract; 2018 May; 214(5):612-618. PubMed ID: 29628124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.
    Dawkins HJ; Sellner LN; Turbett GR; Thompson CA; Redmond SL; McNeal JE; Cohen RJ
    Prostate; 2000 Sep; 44(4):265-70. PubMed ID: 10951489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular complexity of intraductal carcinoma of the prostate.
    Zhu S; Xu N; Zeng H
    Cancer Med; 2024 Jan; 13(2):e6939. PubMed ID: 38379333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate.
    Zhao J; Xu N; Zhu S; Nie L; Zhang M; Zheng L; Cai D; Sun X; Chen J; Dai J; Ni Y; Wang Z; Zhang X; Liang J; Chen Y; Hu X; Pan X; Yin X; Liu H; Zhao F; Zhang B; Chen H; Miao J; Qin C; Zhao X; Yao J; Liu Z; Liao B; Wei Q; Li X; Liu J; Gao AC; Huang H; Shen P; Chen N; Zeng H; Sun G
    Cancer Res; 2024 Jan; 84(1):154-167. PubMed ID: 37847513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features and Prognostic Significance of Intraductal Carcinoma of the Prostate.
    Montironi R; Zhou M; Magi-Galluzzi C; Epstein JI
    Eur Urol Oncol; 2018 May; 1(1):21-28. PubMed ID: 31100224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraductal Carcinoma of the Prostate without High-Grade Invasive Adenocarcinoma: Report of Two Cases and Review of the Literature.
    Ortiz-Rey JA; Bellas-Pereira A; San Miguel-Fraile P; Morellón-Baquera R; Domínguez-Arístegui P; González-Carreró Fojón J
    Arch Esp Urol; 2022 Nov; 75(9):738-745. PubMed ID: 36472055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Hum Pathol; 2014 Aug; 45(8):1572-81. PubMed ID: 24842280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
    Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM
    Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
    Cohen RJ; Wheeler TM; Bonkhoff H; Rubin MA
    Arch Pathol Lab Med; 2007 Jul; 131(7):1103-9. PubMed ID: 17616999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated Intraductal Carcinoma of the Prostate in Prostatectomy Specimens: Report of 2 Cases and Review of the Literature.
    Grypari IM; Logotheti S; Lazaris AC; Kallidonis P; Fokaefs E; Melachrinou M; Zolota V; Tzelepi V
    Int J Surg Pathol; 2020 Dec; 28(8):918-924. PubMed ID: 32456482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal carcinoma of the prostate: a comprehensive and updated review.
    Tsuzuki T
    Int J Urol; 2015 Feb; 22(2):140-5. PubMed ID: 25358604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists.
    Varma M; Egevad L; Algaba F; Berney D; Bubendorf L; Camparo P; Comperat E; Erbersdobler A; Griffiths D; Grobholz R; Haitel A; Hulsbergen-van de Kaa C; Langner C; Loftus B; Lopez-Beltran A; Mayer N; Nesi G; Oliveira P; Oxley J; Rioux-Leclercq N; Seitz G; Shanks J; Kristiansen G
    J Clin Pathol; 2016 Oct; 69(10):852-7. PubMed ID: 26926101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-Depth Comparison of Genetic Variants Demonstrates a Close Relationship Between Invasive and Intraductal Components of Prostate Cancer.
    Vormittag-Nocito E; Acosta AM; Agarwal S; Narayan KD; Kumar R; Al Rasheed MRH; Kajdacsy-Balla A; Behm FG; Mohapatra G
    Mod Pathol; 2023 Jun; 36(6):100130. PubMed ID: 36933394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.